2Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993,42:359-362.
3Torn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of β cell function in autoimmune diabetes. J Clin Endocrinol Metab, 2000,85:4619-4623.
4Gottsater A, Landin-Olsson M, Lernmark A, et al. Glutamate decarboxylase antibody level predicts rate of beta-cell decline in adult-onset diabetes. Diabetes Res Clin Pract, 1995,27:133-140.
5Gardner SG, Gale EA, Williams AJ, et al. Progression to diabetes in relatives with islet autoantibdies. Is it inevitable? Diabetes Care, 1999,22:2049-2054.
6Yu L, Gianani R, Eisenbarth GS. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type 1 diabetes. Diabetes, 1994,43:1229-1233.
7Turner R, Stratton I, Horton V, et al. UKPDS25 autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet, 1997,350:1288-1293.
8Li H, Isomaa B, Taskinen MR, et al. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care, 2000,23:589-594.
9Montana E, Fernandez-Castaner M, Rosel P, et al. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus. Diabete Metab, 1991,17:460-468.
10Kobayashi T, Nakanishi K, Sugimoto T, et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care, 1989,12:7-11.
